These tools will no longer be maintained as of December 31, 2024. Archived website can be found here. PubMed4Hh GitHub repository can be found here. Contact NLM Customer Service if you have questions.


BIOMARKERS

Molecular Biopsy of Human Tumors

- a resource for Precision Medicine *

103 related articles for article (PubMed ID: 10794096)

  • 1. Implementation of HCV-NAT testing in The Netherlands.
    Reesink HW; Cuypers HT; Lelie PN
    Dev Biol (Basel); 2000; 102():105-7. PubMed ID: 10794096
    [No Abstract]   [Full Text] [Related]  

  • 2. Impact of nucleic acid testing for hepatitis B virus, hepatitis C virus, and human immunodeficiency virus on the safety of blood supply in Italy: a 6-year survey.
    Velati C; Romanò L; Fomiatti L; Baruffi L; Zanetti AR;
    Transfusion; 2008 Oct; 48(10):2205-13. PubMed ID: 18631163
    [TBL] [Abstract][Full Text] [Related]  

  • 3. Effect of viral nucleic acid testing on contamination frequency of manufacturing plasma pools.
    Nübling CM; Unkelbach U; Chudy M; Seitz R
    Transfusion; 2008 May; 48(5):822-6. PubMed ID: 18208414
    [TBL] [Abstract][Full Text] [Related]  

  • 4. Correlates of hepatitis C virus (HCV) RNA negativity among HCV-seropositive blood donors.
    Busch MP; Glynn SA; Stramer SL; Orland J; Murphy EL; Wright DJ; Kleinman S;
    Transfusion; 2006 Mar; 46(3):469-75. PubMed ID: 16533292
    [TBL] [Abstract][Full Text] [Related]  

  • 5. Screening of blood donors for hepatitis C virus RNA with the MagNA Pure-COBAS AmpliScreen method.
    Palomäki P; Wessberg S; Tuomi K; Laitinen H
    Transfusion; 2005 Sep; 45(9):1518-22. PubMed ID: 16131386
    [TBL] [Abstract][Full Text] [Related]  

  • 6. Preventing disease transmission by deceased tissue donors by testing blood for viral nucleic acid.
    Strong DM; Nelson K; Pierce M; Stramer SL
    Cell Tissue Bank; 2005; 6(4):255-62. PubMed ID: 16308764
    [TBL] [Abstract][Full Text] [Related]  

  • 7. [HCV RNA assessment by PCR technique for screening post-transfusion HCV infection among blood donors].
    Xing W; Xu H; Ma R; Zheng H
    Zhonghua Gan Zang Bing Za Zhi; 2002 Jun; 10(3):211-2. PubMed ID: 12113682
    [TBL] [Abstract][Full Text] [Related]  

  • 8. Is an assay for simultaneous detection of hepatitis C virus core antigen and antibody a valuable alternative to nucleic acid testing?
    Laperche S; Elghouzzi MH; Morel P; Asso-Bonnet M; Le Marrec N; Girault A; Servant-Delmas A; Bouchardeau F; Deschaseaux M; Piquet Y
    Transfusion; 2005 Dec; 45(12):1965-72. PubMed ID: 16371051
    [TBL] [Abstract][Full Text] [Related]  

  • 9. Evaluation of an automated high-volume extraction method for viral nucleic acids in comparison to a manual procedure with preceding enrichment.
    Hourfar MK; Schmidt M; Seifried E; Roth WK
    Vox Sang; 2005 Aug; 89(2):71-6. PubMed ID: 16101686
    [TBL] [Abstract][Full Text] [Related]  

  • 10. At last--a national blood policy?
    Aledort LM
    Hosp Pract; 1979 Jul; 14(7):11, 15. PubMed ID: 478506
    [No Abstract]   [Full Text] [Related]  

  • 11. Scottish experience with NAT.
    Jarvis LM; Simmonds P
    Transfus Med; 2002 Aug; 12(4):259-64. PubMed ID: 12220255
    [No Abstract]   [Full Text] [Related]  

  • 12. Evaluation of a multiplex human immunodeficiency virus-1, hepatitis C virus, and hepatitis B virus nucleic acid testing assay to detect viremic blood donors in northern Thailand.
    Nantachit N; Thaikruea L; Thongsawat S; Leetrakool N; Fongsatikul L; Sompan P; Fong YL; Nichols D; Ziermann R; Ness P; Nelson KE
    Transfusion; 2007 Oct; 47(10):1803-8. PubMed ID: 17880604
    [TBL] [Abstract][Full Text] [Related]  

  • 13. Accuracy of hepatitis C virus core antigen testing in pools among seroconverters.
    Beer N; Shinar E; Novack L; Safi J; Soliman H; Yaari A; Goldman-Levi R; Yahalom V; Bolotin A; Sarov B
    Transfusion; 2006 Oct; 46(10):1822-8. PubMed ID: 17002640
    [TBL] [Abstract][Full Text] [Related]  

  • 14. Relative sensitivities of licensed nucleic acid amplification tests for detection of viremia in early human immunodeficiency virus and hepatitis C virus infection.
    Busch MP; Glynn SA; Wright DJ; Hirschkorn D; Laycock ME; McAuley J; Tu Y; Giachetti C; Gallarda J; Heitman J; Kleinman SH;
    Transfusion; 2005 Dec; 45(12):1853-63. PubMed ID: 16371038
    [TBL] [Abstract][Full Text] [Related]  

  • 15. Chiron's procleix HIV-1/HCV assay receives FDA approval.
    Expert Rev Mol Diagn; 2002 Mar; 2(2):94. PubMed ID: 11962342
    [No Abstract]   [Full Text] [Related]  

  • 16. Evaluation of a new molecular assay for detection of human immunodeficiency virus type 1 RNA, hepatitis C virus RNA, and hepatitis B virus DNA.
    McCormick MK; Dockter J; Linnen JM; Kolk D; Wu Y; Giachetti C
    J Clin Virol; 2006 Jul; 36(3):166-76. PubMed ID: 16427802
    [TBL] [Abstract][Full Text] [Related]  

  • 17. NAT update: where are we today?
    Stramer SL
    Dev Biol (Basel); 2002; 108():41-56. PubMed ID: 12220142
    [TBL] [Abstract][Full Text] [Related]  

  • 18. Coinfection with HIV and HCV in a blood bank population in Dar es Salaam, Tanzania.
    Waddell RD; Magesa PM; Pallangyo KJ; Matee M; Bakari M; von Reyn F; Ziermann R
    J Clin Virol; 2006 Jul; 36(3):237-8. PubMed ID: 16723273
    [No Abstract]   [Full Text] [Related]  

  • 19. Identification of low HBV-DNA levels by nucleic acid amplification test (NAT) in blood donors.
    Dettori S; Candido A; Kondili LA; Chionne P; Taffon S; Genovese D; Iudicone P; Miceli M; Rapicetta M
    J Infect; 2009 Aug; 59(2):128-33. PubMed ID: 19586663
    [TBL] [Abstract][Full Text] [Related]  

  • 20. Experience of mandatory nucleic acid test (NAT) screening across all blood organizations in Germany: NAT yield versus breakthrough transmissions.
    Nübling CM; Heiden M; Chudy M; Kress J; Seitz R; Keller-Stanislawski B; Funk MB
    Transfusion; 2009 Sep; 49(9):1850-8. PubMed ID: 19453976
    [TBL] [Abstract][Full Text] [Related]  

    [Next]    [New Search]
    of 6.